Urology · Freedom, CA
NPI
1801981485
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
160 Green Valley Rd, Suite 203
Freedom, CA, 95019
Phone (831) 728-4227
Groups this clinician bills Medicare through
Medicare paid, 2024
$131K
19,838 services
Medicare patients, 2024
489
Average age 75
Drug cost, 2024
$204K
2,233 prescriptions
Company payments, 2025
$24.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Philip A Knorr was code 81002 (clinical chemistry), 676 times for 383 patients. In total Philip A Knorr billed 19,838 services in 41 codes, and Medicare paid $131K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81002 Clinical Chemistry | Office | 676 | 383 | $3.38 | $2,288 |
| 99213 Office E&M - Established | Office | 641 | 400 | $66.95 | $43K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 210 | 25 | $139.01 | $29K |
| 96372 Injection Administration | Office | 143 | 27 | $11.63 | $1,664 |
| 99214 Office E&M - Established | Office | 125 | 91 | $104.53 | $13K |
| 96402 Chemotherapy Administration | Office | 66 | 24 | $29.16 | $1,924 |
| 99203 Office E&M - New | Office | 54 | 54 | $73.34 | $3,961 |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 37 | 32 | $41.67 | $1,542 |
| 52000 Cystourethroscopy | Office | 35 | 33 | $210.21 | $7,357 |
| 99204 Office E&M - New | Office | 31 | 31 | $110.74 | $3,433 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 18 | 14 | $2.02 | $36.29 |
| 51700 Other Organ Systems | Office | 16 | 13 | $68.40 | $1,094 |
| 99212 Office E&M - Established | Office | 14 | 13 | $37.39 | $523 |
| 76872 Ultrasound - Nonspecific | Office | 14 | 14 | $136.00 | $1,904 |
| 76942 Ultrasound - Nonspecific | Office | 14 | 14 | $54.34 | $761 |
By year: 2022 $130K for 17,347 services; 2023 $122K for 19,953 services; 2024 $131K for 19,838 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 676 | 383 | $3.38 | $2,288 |
Medicare prescription drug claims, 2024
In 2024, the drug Philip A Knorr prescribed most often to Medicare patients was Tamsulosin Hcl, with 649 prescriptions and refills. In total Philip A Knorr wrote 2,233 Medicare prescriptions that cost $204K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 649 | 1,710 | 201 | $9,720 |
| Finasteride Generic | 498 | 1,311 | 148 | $6,597 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 288 | 693 | 96 | $6,466 |
| Imipramine Hcl Generic | 199 | 434 | 54 | $3,732 |
| Myrbetriq Mirabegron | 126 | 243 | 36 | $110K |
| Ciprofloxacin Hcl Generic | 53 | 53 | 36 | $267 |
| Oxybutynin Chloride Generic | 50 | 109 | 13 | $941 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 44 | 44 | 20 | $853 |
| Solifenacin Succinate Generic | 41 | 85 | Under 11 | $2,002 |
| Elmiron Pentosan Polysulfate Sodium | 30 | 34 | Under 11 | $27K |
| Estradiol Generic | 23 | 63 | Under 11 | $1,403 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 21 | 21 | Under 11 | $296 |
| Allopurinol Generic | 21 | 63 | Under 11 | $260 |
| Potassium Citrate Er Potassium Citrate | 18 | 41 | Under 11 | $1,314 |
| Dutasteride Generic | 17 | 51 | Under 11 | $1,475 |
Brand drugs: 187 claims; generic drugs: 2,046 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Philip A Knorr $24.99 ($24.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Accord Healthcare, Inc. with $24.99.
| Company | Payments | Amount |
|---|---|---|
| Accord Healthcare, Inc. | 1 | $24.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.